ESTRO 2025 - Abstract Book

S780

Clinical - Gynaecology

ESTRO 2025

Conclusion: Hysterectomy followed by adjuvant chemotherapy and h-RT was safe. High-grade toxicities were low and locoregional control was excellent without compromise in distant control. This regimen is worthy of further evaluation in a randomized trial.

Keywords: Hypofractionated radiotherapy, endometrial cancer

References: [i] Leung E, Gladwish AP, Davidson M, et al. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial. JAMA Oncol . 2022;8(6):1-9. doi:10.1001/jamaoncol.2022.0362